Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVNO | Common Stock | Options Exercise | +388 | +15.52% | 2.89K | Nov 16, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVNO | Restricted Stock Units | Options Exercise | $0 | -388 | -100% | $0.00* | 0 | Nov 16, 2021 | Common Stock | 388 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") converts into one share of common stock of enVVeno Medical Corporation. |
F2 | The RSUs were issued to the Reporting person on November 27, 2018, in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the "Plan"), subject to vesting and settlement as described in the person's Form 4, as filed on November 6, 2019. The vesting and settlement of 388 RSUs occurred on November 16, 2021. |